- Home
- ORIC vs LASR Comparison
ORIC vs LASR Comparison
Compare ORIC & LASR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORIC
- LASR
- Stock Information
- Founded
- ORIC 2014
- LASR 2000
- Country
- ORIC United States
- LASR United States
- Employees
- ORIC N/A
- LASR N/A
- Industry
- ORIC Biotechnology: Pharmaceutical Preparations
- LASR Semiconductors
- Sector
- ORIC Health Care
- LASR Technology
- Exchange
- ORIC Nasdaq
- LASR Nasdaq
- Market Cap
- ORIC 974.1M
- LASR 903.8M
- IPO Year
- ORIC 2020
- LASR 2018
- Fundamental
- Price
- ORIC $11.07
- LASR $31.20
- Analyst Decision
- ORIC Strong Buy
- LASR Strong Buy
- Analyst Count
- ORIC 8
- LASR 6
- Target Price
- ORIC $16.57
- LASR $27.42
- AVG Volume (30 Days)
- ORIC 961.7K
- LASR 880.6K
- Earning Date
- ORIC 11-11-2025
- LASR 11-06-2025
- Dividend Yield
- ORIC N/A
- LASR N/A
- EPS Growth
- ORIC N/A
- LASR N/A
- EPS
- ORIC N/A
- LASR N/A
- Revenue
- ORIC N/A
- LASR $216,913,000.00
- Revenue This Year
- ORIC N/A
- LASR $23.15
- Revenue Next Year
- ORIC N/A
- LASR $8.43
- P/E Ratio
- ORIC N/A
- LASR N/A
- Revenue Growth
- ORIC N/A
- LASR 9.79
- 52 Week Low
- ORIC $3.90
- LASR $6.20
- 52 Week High
- ORIC $14.67
- LASR $31.59
- Technical
- Relative Strength Index (RSI)
- ORIC 58.52
- LASR 69.41
- Support Level
- ORIC $10.37
- LASR $27.22
- Resistance Level
- ORIC $11.16
- LASR $30.56
- Average True Range (ATR)
- ORIC 0.54
- LASR 1.34
- MACD
- ORIC 0.04
- LASR -0.13
- Stochastic Oscillator
- ORIC 82.14
- LASR 89.64
About ORIC Oric Pharmaceuticals Inc.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.
About LASR nLIGHT Inc.
nLight Inc is a United States-based company provider of power semiconductor and fiber lasers for aerospace and defense, industrial, and microfabrication applications. It designs, manufactures, and sells a range of power semiconductor lasers and fiber lasers that are typically integrated into laser systems. It operates in two segments: Laser Products, which includes semiconductor lasers, fiber lasers, and directed energy products; and Development segment includes revenue earned from research and development contracts. The majority of its revenue is generated from the Laser segment. The company's geographical segments include North America, Asia Pacific, and EMEA.